Cargando…

Therapeutic Effects of a Traditional Chinese Medicine Formula Plus Tamoxifen vs. Tamoxifen for the Treatment of Mammary Gland Hyperplasia: A Meta-Analysis of Randomized Trials

As a common disorder that accounts for over 70% of all breast disease cases, mammary gland hyperplasia (MGH) causes a severe problem for the quality of patients' life, and confers an increased risk of breast carcinoma. However, the etiology and pathogenesis of MGH remain unclear, and the safety...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hao-Tian, Liu, Hong-Hong, Yang, Yu-Xue, Wang, Tao, Zhou, Xue-Lin, Yu, Yang, Li, Su-Na, Zheng, Yi, Zhang, Ping, Wang, Rui-Lin, Li, Jian-Yu, Wei, Shi-Zhang, Li, Kun, Li, Peng-Yan, Qian, Li-Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801403/ https://www.ncbi.nlm.nih.gov/pubmed/29456506 http://dx.doi.org/10.3389/fphar.2018.00045

Ejemplares similares

The influence of tamoxifen on normal mouse mammary gland homeostasis
por: Shehata, Mona, et al.
Publicado: (2014)

Anti-Inflammatory Effect of a TCM Formula Li-Ru-Kang in Rats With Hyperplasia of Mammary Gland and the Underlying Biological Mechanisms
por: Wang, Yingying, et al.
Publicado: (2018)

Anti-hyperplasia Effects of Total Saponins From Phytolaccae Radix in Rats With Mammary Gland Hyperplasia via Inhibition of Proliferation and Induction of Apoptosis
por: Li, Xiaoliang, et al.
Publicado: (2018)

The Modulatory Properties of Li-Ru-Kang Treatment on Hyperplasia of Mammary Glands Using an Integrated Approach
por: Wei, Shizhang, et al.
Publicado: (2018)

PKM2–c-Myc–Survivin Cascade Regulates the Cell Proliferation, Migration, and Tamoxifen Resistance in Breast Cancer
por: Yu, Pian, et al.
Publicado: (2020)

Interactions Between Natural Products and Tamoxifen in Breast Cancer: A Comprehensive Literature Review
por: Yen, Christine, et al.
Publicado: (2022)

Polysaccharide Peptide Extract From Coriolus versicolor Increased T(max) of Tamoxifen and Maintained Biochemical Serum Parameters, With No Change in the Metabolism of Tamoxifen in the Rat
por: Razmovski-Naumovski, Valentina, et al.
Publicado: (2022)

Tamoxifen activates Nrf2-dependent SQSTM1 transcription to promote endometrial hyperplasia
por: Feng, Lifeng, et al.
Publicado: (2017)

Tamoxifen Twists Again: On and Off-Targets in Macrophages and Infections
por: Sfogliarini, Chiara, et al.
Publicado: (2022)

Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer
por: Yao, Jingwei, et al.
Publicado: (2020)

Nationwide Case-Control Study Examining the Association between Tamoxifen Use and Alzheimer’s Disease in Aged Women with Breast Cancer in Taiwan
por: Liao, Kuan-Fu, et al.
Publicado: (2017)

Bone Protective Effects of Danggui Buxue Tang Alone and in Combination With Tamoxifen or Raloxifene in vivo and in vitro
por: Zhou, Li-Ping, et al.
Publicado: (2018)

Physiologically Based Pharmacokinetic Modeling of Tamoxifen and its Metabolites in Women of Different CYP2D6 Phenotypes Provides New Insight into the Tamoxifen Mass Balance
por: Dickschen, Kristin, et al.
Publicado: (2012)

Molecular Action of Tamoxifen in the Ovaries of Rats with Mammary Neoplasia
por: Nynca, Anna, et al.
Publicado: (2023)

Enhanced anti-mammary gland cancer activities of tamoxifen-loaded erythropoietin-coated drug delivery system
por: Beh, Chaw Yee, et al.
Publicado: (2019)

Long-Term Use of Tamoxifen Is Associated With a Decreased Subsequent Meningioma Risk in Patients With Breast Cancer: A Nationwide Population-Based Cohort Study
por: Sun, Li-Min, et al.
Publicado: (2019)

Tamoxifen Use Correlates with Increased Risk of the First Episode of Ischemic Cerebrovascular Disease in Older Women with Breast Cancer: A Case-Control Study in Taiwan
por: Lai, Shih-Wei, et al.
Publicado: (2017)

The response of anti-VEGF therapy and tamoxifen withdrawal of tamoxifen-induced cystoid macular edema in the same patient
por: Li, Chuanyu, et al.
Publicado: (2021)

Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its Metabolites
por: Khalaj, Zahra, et al.
Publicado: (2019)

Baihe Zhimu formula attenuates the efficacy of tamoxifen against breast cancer in mice through modulation of CYP450 enzymes
por: Li, Hailong, et al.
Publicado: (2019)

Disruption of the ER-α36-EGFR/HER2 Positive Regulatory Loops Restores Tamoxifen Sensitivity in Tamoxifen Resistance Breast Cancer Cells
por: Yin, Li, et al.
Publicado: (2014)

Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review
por: Hind, D, et al.
Publicado: (2007)

Integrated Metabolomics and Network Pharmacology Revealed Hong-Hua-Xiao-Yao Tablet’s Effect of Mediating Hormone Synthesis in the Treatment of Mammary Gland Hyperplasia
por: Gao, Ziqing, et al.
Publicado: (2022)

Tamoxifen retinopathy: a case report
por: Wang, Lingling, et al.
Publicado: (2015)

Construction of microneedle of Atractylodes macrocephala Rhizoma aqueous extract and effect on mammary gland hyperplasia based on intestinal flora
por: Ping, Yang, et al.
Publicado: (2023)

Effects of Atractylodes Macrocephala Rhizoma polysaccharide on intestinal microbiota composition in rats with mammary gland hyperplasia
por: Ping, Yang, et al.
Publicado: (2023)

Commentary: Anti-hyperplasia effects of total saponins from phytolaccae radix in rats with mammary gland hyperplasia via inhibition of proliferation and induction of apoptosis
por: Cai, Liying, et al.
Publicado: (2023)

LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer
por: Xue, Xingyang, et al.
Publicado: (2015)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
por: Wang, Yuntao, et al.
Publicado: (2021)

A state-of-the-art review of tamoxifen as a potential therapeutic for duchenne muscular dystrophy
por: Botti, Valeria, et al.
Publicado: (2022)

IARC on tamoxifen.
Publicado: (1996)

Tamoxifen evolution
por: Howell, A., et al.
Publicado: (2023)

Selective Estrogen Receptor Modulator-Like Activities of Herba epimedii Extract and its Interactions With Tamoxifen and Raloxifene in Bone Cells and Tissues
por: Zhou, Liping, et al.
Publicado: (2021)

Survival in renal cell carcinoma: a randomized evaluation of tamoxifen vs interleukin-2, α-interferon (leucocyte) and tamoxifen
Publicado: (2000)

Survival in renal cell carcinoma-a randomized evaluation of tamoxifen vs interleukin 2, alpha-interferon (leucocyte) and tamoxifen.
por: Henriksson, R., et al.
Publicado: (1998)

Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
por: Moon, Seo Yun, et al.
Publicado: (2021)

Survival in renal cell carcinoma: a randomized evaluation of tamoxifen vs interleukin-2, α-interferon (leucocytic) and tamoxifen – reply
Publicado: (2000)

The mechanism of tamoxifen in breast cancer prevention
por: Yu, F, et al.
Publicado: (2001)

Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial
por: Li, Jian-wei, et al.
Publicado: (2018)

Liver hyperplasia after tamoxifen induction of Myc in a transgenic medaka model
por: Menescal, Luciana A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ouinff3dpbv8m6h2dq6ddimvp4